DERM - Company ID 0001867066
Journey Medical Corp trades as DERM. In its fiscal 2025 annual report the company posted revenue of $61.86M, up 10.2% from the prior year and net income of -$11.43M. This page tracks Journey Medical Corp through 210 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 5 fiscal years Journey Medical Corp's revenue grew from $44.53M to $61.86M, a compound annual growth rate of 6.8%. Net profit margin compressed from 11.9% to -18.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| SCHEDULE 13G | - | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
| Insider trade | 4 | 2026-04-24 |
| Insider trade | 4 | 2026-04-24 |
| Insider trade | 4 | 2026-04-24 |
The largest companies sharing Journey Medical Corp's SEC industry classification (pharmaceutical preparations).
Journey Medical Corp reported revenue of $61.86M for fiscal year 2025, an increase of 10.2% year over year.
In its latest fiscal year Journey Medical Corp reported a net loss of $11.43M.